Confirmatory Assignment

Recorded: 2022-05-11 Pages: 9

Assignor

AFFIRIS AG

Executed: 2022-02-23

Assignee

AFFIRIS CVD GMBH

KARL-FARKAS-GASSE 22, VIENNA, 1030, AUSTRIA

Covered Properties (5)

Peptide Vaccines for Hypercholesterolemia Related Diseases

Patent: 11,980,657 →

Application: 17/145,571 →

Publication: US 2021/0138048

A Vaccine Capable of Inducing Formation of Antibodies Directed to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Vivo.

Patent: 9,533,030 →

Application: 14/418,139 →

Publication: US 2015/0306191

Treatments Using a Peptide and/or Vaccine

Patent: 9,999,659 →

Application: 15/367,711 →

Publication: US 2017/0112908

Peptide Vaccines Usable for Hypercholesterolemia Related Diseases.

Patent: 10,933,123 →

Application: 15/984,800 →

Publication: US 2018/0289781

Peptide Vaccines Against PCSK9

Patent: 10,004,791 →

Application: 15/122,316 →

Publication: US US20170065689A1

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.